VITRO DIAGNOSTICS, INC. (OTCMKTS:VODG) Files An 8-K Entry into a Material Definitive Agreement

VITRO DIAGNOSTICS, INC. (OTCMKTS:VODG) Files An 8-K Entry into a Material Definitive Agreement

Story continues below

ITEM 1.01

ENTRY INTO MATERIAL DEFINITIVE AGREEMENTS

Amendment to Memorandum of
Understanding

Effective April 14, 2017, the Board of Directors of Vitro
Diagnostics, Inc. (the Company) approved of an Amendment to a
Memorandum of Understanding (MOU) between the Company and
Caribbean GC Development Fund, Ltd., a Grand Cayman corporation
(Caribbean GC) (the Amendment). A copy of the MOU was previously
filed as an exhibit to the Companys Current Report on Form 8-K
dated March 23, 2017 and filed with the Commission on March 29,
2017.

The Amendment extends the closing date of a debt investment as
described in the MOU from April 15, 2017 to May 31, 2017. A copy
of the Amendment is filed herewith as Exhibit 10.1.

ITEM 9.01:EXHIBITS

Item

Title

10.1

Amendment to Memorandum of Understanding


About VITRO DIAGNOSTICS, INC. (OTCMKTS:VODG)

Vitro Diagnostics, Inc., doing business as Vitro Biopharma, is engaged in the development, manufacturing and distribution of stem cell products and related tools for use in research, drug discovery and clinical trials. The Company’s clinical products include clinical grade MSC-Gro for mesenchymal stem cell (MSC) expansion prior to transplantation; an equine MSC cell line with application to treatment of skeletal muscular conditions, such as tendonitis, ligament injury, osteoarthritis and accelerated bone fracture healing, and others; testing and therapies related to endogenous stem cell activation; diagnostic testing of stem cell activation and determination of stem cell functional status, and cell-based assays for discovery of stem cell activation agents and new drugs for the treatment of osteoporosis. The Company offers cancer-associated fibroblasts (CAFs), which are used in the discovery of a new type of CAFs present in pancreatic cancer tumors, called pancreatic stellate cells.

VITRO DIAGNOSTICS, INC. (OTCMKTS:VODG) Recent Trading Information

VITRO DIAGNOSTICS, INC. (OTCMKTS:VODG) closed its last trading session 00.000 at 0.100 with 14,309 shares trading hands.

An ad to help with our costs